Vifor Pharma AG operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vifor Pharma AG with three other
drug stores in Europe:
sales of 1.64 billion Euro [US$1.94 billion]
of which 157%
Selcuk Ecza Deposu Ticaret ve Sanayi AS
(8.64 billion Turkish Liras [US$2.35 billion]
of which 100%
was Medical and Hospital Equipment), and
based in Poland
(7.08 billion Polish New Zlotys [US$1.97 billion]
of which 99%
was Pharmaceutical Wholesale).
During the year ended December of 2016, sales at
Vifor Pharma AG were 4.12 billion Swiss Francs (US$4.19 billion).
increase of 8.6%
versus 2015, when the company's sales were 3.79 billion Swiss Francs.
This was the fifth consecutive year of sales increases at Vifor Pharma AG
(and since 2011, sales have increased a total of 29%).
Sales of Vifor Pharma saw an increase
that was more than double the company's growth rate: sales were up
20.7% in 2016, from
967.02 million Swiss Francs to 1.17 billion Swiss Francs.